rxstat › Shortages › Gliclazide

Gliclazide shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Gliclazide products are in shortage in Canada (2 of 20 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 of 20
In shortage since
Nov 1, 2024
Reports on file
92
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
GLICLAZIDE MR
60MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02524864 · since Mar 26, 2025, no end estimate · Demand increase for the drug.
Active shortage
GLICLAZIDE MR
30MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02524856 · since Nov 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
TARO-GLICLAZIDE MR
60MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02439328 · ended May 20, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-GLICLAZIDE
80MG · TABLET · TEVA CANADA LIMITED
DIN 02238103 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-GLICLAZIDE
80MG · TABLET · TEVA CANADA LIMITED
DIN 02238103 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP GLICLAZIDE-MR
60MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02429772 · ended Jan 5, 2026 · Demand increase for the drug.
Resolved
TARO-GLICLAZIDE MR
30MG · TABLET (EXTENDED-RELEASE) · SUN PHARMA CANADA INC
DIN 02463571 · ended Nov 5, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP GLICLAZIDE-MR
30MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02429764 · ended Nov 10, 2025 · Demand increase for the drug.
Resolved
APO-GLICLAZIDE
80MG · TABLET · APOTEX INC
DIN 02245247 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-GLICLAZIDE MR
30MG · TABLET (EXTENDED-RELEASE) · MYLAN PHARMACEUTICALS ULC
DIN 02438658 · ended Aug 5, 2025 · Demand increase for the drug.
Resolved
APO-GLICLAZIDE
80MG · TABLET · APOTEX INC
DIN 02245247 · ended Jul 31, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-GLICLAZIDE
80MG · TABLET · TEVA CANADA LIMITED
DIN 02238103 · ended Jun 25, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Gliclazide is currently affected by 2 active shortage reports filed with Health Canada by SANIS HEALTH INC.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Gliclazide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BB).

Recent changes

Common questions

When will Gliclazide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Gliclazide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageMetformin3 of 33 reported products affected · est. return May 15, 2026

All blood glucose lowering drugs, excl. insulins shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.